Logo
  1. IR@JU
  2. Faculty Council of Engineering & Technology
  3. Department of Pharmaceutical Technology
  4. Dissertations
Please use this identifier to cite or link to this item: http://20.198.91.3:8080/jspui/handle/123456789/2059
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorGhosh, Sujoy-
dc.contributor.advisorChatterjee, Sharmila-
dc.contributor.advisorSamanta, Amalesh-
dc.contributor.authorSarkar, Chandrima-
dc.date.accessioned2023-03-03T08:08:00Z-
dc.date.available2023-03-03T08:08:00Z-
dc.date.issued2019-
dc.date.submitted2019-
dc.identifier.otherDC4516-
dc.identifier.urihttp://20.198.91.3:8080/jspui/handle/123456789/2059-
dc.format.extent[v], 77 p.en_US
dc.language.isoenen_US
dc.publisherJadavpur Univesity, Kolkata, West Bengalen_US
dc.subjectType 2 Diabetesen_US
dc.subjectTeneligliptinen_US
dc.subjectSitagliptinen_US
dc.subjectType 2 diabetes mellitus (T2DM)en_US
dc.titleA comparative prospective study of the safety of Teneligliptin and Sitagliptin to evaluate QTC prolongation in Indian type 2 diabetes patientsen_US
dc.typeTexten_US
dc.departmentJadavpur University. Department of Pharmaceutical Technologyen_US
Appears in Collections:Dissertations

Files in This Item:
File Description SizeFormat 
M.Pharm. (Pharmaceutical Technology) Chandrima Sarkar.pdf1.41 MBAdobe PDFView/Open
Show simple item record


Items in IR@JU are protected by copyright, with all rights reserved, unless otherwise indicated.